HomeCompareSNV vs MRK

SNV vs MRK: Dividend Comparison 2026

SNV yields 3.12% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNV wins by $189.3K in total portfolio value· pulled ahead in Year 2
10 years
SNV
SNV
● Live price
3.12%
Share price
$50.05
Annual div
$1.56
5Y div CAGR
50.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$246.1K
Annual income
$119,147.98
Full SNV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SNV vs MRK

📍 SNV pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNV
Annual income on $10K today (after 15% tax)
$264.94/yr
After 10yr DRIP, annual income (after tax)
$101,275.78/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SNV beats the other by $92,947.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNV + MRK for your $10,000?

SNV: 50%MRK: 50%
100% MRK50/50100% SNV
Portfolio after 10yr
$151.5K
Annual income
$64,473.06/yr
Blended yield
42.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SNV
Analyst Ratings
18
Buy
14
Hold
Consensus: Buy
Price Target
$58.50
+16.9% upside vs current
Range: $51.00 — $70.00
Altman Z
0.4
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNV buys
0
MRK buys
0
No recent congressional trades found for SNV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNVMRK
Forward yield3.12%2.76%
Annual dividend / share$1.56$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR50.4%32.7%
Portfolio after 10y$246.1K$56.8K
Annual income after 10y$119,147.98$9,798.13
Total dividends collected$212.0K$28.9K
Payment frequencyquarterlyquarterly
SectorFinancialsHealthcare
Analyst consensusBuyBuy
Analyst price target$58.50$128.54

Year-by-year: SNV vs MRK ($10,000, DRIP)

YearSNV PortfolioSNV Income/yrMRK PortfolioMRK Income/yrGap
1$11,169$468.78$11,206$366.19$37.00MRK
2← crossover$12,687$735.93$12,650$502.35+$37.00SNV
3$14,750$1,175.00$14,407$694.19+$343.00SNV
4$17,702$1,920.17$16,585$967.82+$1.1KSNV
5$22,181$3,239.31$19,342$1,363.89+$2.8KSNV
6$29,438$5,705.11$22,913$1,947.19+$6.5KSNV
7$42,142$10,643.09$27,662$2,823.89+$14.5KSNV
8$66,508$21,415.80$34,159$4,173.35+$32.3KSNV
9$118,670$47,506.68$43,337$6,308.80+$75.3KSNV
10$246,125$119,147.98$56,776$9,798.13+$189.3KSNV

SNV vs MRK: Complete Analysis 2026

SNVFinancials

Synovus Financial Corp. operates as the bank holding company for Synovus Bank that provides commercial and retail banking products and services. It operates through three segments: Community Banking, Wholesale Banking, and Financial Management Services. The company's commercial banking services include treasury management, asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate loans. Its retail banking services comprise accepting customary types of demand and savings deposits accounts; mortgage, installment, and other consumer loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet-based banking services; and bank credit and debit card services. The company also offers various other financial services, including portfolio management for fixed-income securities, investment banking, execution of securities transactions as a broker/dealer, and financial planning services, as well as provides individual investment advice on equity and other securities. As of December 31, 2020, it operated through 289 branches and 389 ATMs in Alabama, Florida, Georgia, South Carolina, and Tennessee. The company was founded in 1888 and is headquartered in Columbus, Georgia.

Full SNV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SNV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNV vs SCHDSNV vs JEPISNV vs OSNV vs KOSNV vs MAINSNV vs JNJSNV vs ABBVSNV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.